跳至主要内容
临床试验/NCT02213159
NCT02213159已完成2 期

Intraoperative Dexmedetomidine Versus Morphine for Postoperative Analgesia After Laparoscopic Bariatric Surgery

American University of Beirut Medical Center1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2014年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
60
试验地点
1
主要终点
Total dose of morphine consumed in Post Anesthesia Care Unit (PACU)

研究概览

简要总结

The purpose of this study is to determine if Dexmedetomidine given at the end of surgery will reduce postoperative morphine consumption and improve postoperative quality of recovery as compared to morphine in patients undergoing laparoscopic bariatric surgery.

详细描述

effect of Dexmedetomidine bolus on postoperative morphine requirements

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Body Mass Index > 40 kg/m2 or BMI > 35 kg/m2 with comorbid conditions such as hypertension, diabetes or sleep apnea
  • American Society of Anesthesiologists class I or II
  • Undergoing laparoscopic sleeve gastrectomy bariatric surgery

排除标准

  • Allergy to morphine or its derivatives
  • Allergy to α-2 adrenergic agonists
  • weight over 180 kg
  • history of uncontrolled hypertension
  • heart block greater than first degree
  • prolonged QT interval
  • clinically significant neurologic, cardiovascular, renal, hepatic, or gastrointestinal diseases
  • received an opioid analgesic medication within a 24 h period prior to surgery
  • history of alcohol, drug abuse or chronic opioid intake
  • history of psychiatric disorder
  • pregnant or breastfeeding.

研究组 & 干预措施

Dexmedetomidine

Active Comparator

prior to anticipated end of surgery bolus of 1 microgram/kg Dexmedetomidine intravenously over 10 minutes followed by 0.5 micrograms/kilogram/hour intravenous infusion until removal of laparoscopes

干预措施: Dexmedetomidine (Drug)

Morphine

Active Comparator

prior to anticipated completion of surgery morphine 0.08 mg/kilogram intravenous bolus over 10 minutes followed by a saline infusion until removal of the laparoscopes

干预措施: Morphine (Drug)

结局指标

主要结局

Total dose of morphine consumed in Post Anesthesia Care Unit (PACU)

时间窗: At discharge from the PACU

次要结局

  • Time to first morphine requirement in PACU(in the PACU)
  • Numeric Rating Scale (NRS) for Pain(in the PACU and at 24 hours)
  • NRS for nausea(in the PACU)
  • incidence of pruritus(in the PACU)
  • incidence of vomiting or retching(in the PACU)
  • incidence of respiratory complications(in the PACU)
  • time to discharge readiness in PACU(in the PACU)
  • total morphine consumption at 24 hours(at 24 hours)
  • Quality of Recovery (QoR-40) score at 24 hours(at 24 hours)
  • overall satisfaction at one month(one month after surgery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Dexmedetomidine for Postoperative Analgesia After... | 临床试验